within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07A_IntestinalAntiinfectives.A07AA51_NeomycinCombinations;

model NeomycinCombinations
  extends Pharmacolibrary.Drugs.ATC.A.A07AA51;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A07AA51</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Neomycin is an aminoglycoside antibiotic typically used in combination with other agents for the treatment of intestinal infections and for preoperative bowel sterilization. It is intended for oral administration due to its poor absorption and is mostly used to suppress gut flora. The drug is not absorbed systematically, so it is rarely used for systemic infections. Neomycin-containing combinations are approved for use today, though usage has declined due to safer alternatives and concern for nephrotoxicity and ototoxicity.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adults, oral administration of neomycin in typical combination preparations; population: adults, all sexes, ages 18-65; almost no systemic absorption expected with oral neomycin.</p><h4>References</h4><ol><li><p>Namasivayam, S, et al., &amp; Sher, A (2023). The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability. <i>mBio</i> 14(2) e0035323–None. DOI:<a href=&quot;https://doi.org/10.1128/mbio.00353-23&quot;>10.1128/mbio.00353-23</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36877010/&quot;>https://pubmed.ncbi.nlm.nih.gov/36877010</a></p></li><li><p>Nevado, R, et al., &amp; Grasa, L (2015). Neomycin and bacitracin reduce the intestinal permeability in mice and increase the expression of some tight-junction proteins. <i>Revista espanola de enfermedades digestivas</i> 107(11) 672–676. DOI:<a href=&quot;https://doi.org/10.17235/reed.2015.3868/2015&quot;>10.17235/reed.2015.3868/2015</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26541656/&quot;>https://pubmed.ncbi.nlm.nih.gov/26541656</a></p></li><li><p>Xing, J, et al., &amp; Zhong, D (2005). Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract. <i>The Journal of pharmacy and pharmacology</i> 57(6) 743–750. DOI:<a href=&quot;https://doi.org/10.1211/0022357056244&quot;>10.1211/0022357056244</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15969929/&quot;>https://pubmed.ncbi.nlm.nih.gov/15969929</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end NeomycinCombinations;
